Viage Therapeutics
PrivateLast Round
Seed
Jan 6, 2022
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Viage Therapeutics operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Seed round in January 2022.
Viage Therapeutics is a biotechnology company that develops drugs to treat psychiatric and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viage Therapeutics Comparables
Compare Viage Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stellate Therapeutics Inc. | 84% | |
| Axial Therapeutics | 77% | |
| Holobiome | 73% |
For institutional investors. Book with your work email.
Viage Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Viage Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Remiges Ventures | Seed |
| ANRI株式会社 | Seed |
| Miyako Capital | Seed |
| Kyoto University Innovation Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 116% MoM.
- Jul 24, 2026
Monthly visitors increased 117% MoM.
For institutional investors. Book with your work email.
Viage Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Viage Therapeutics's valuation, stock price, and market status.
Is Viage Therapeutics a public or private company?
Viage Therapeutics is a private company.
What is the current stock price of Viage Therapeutics?
Viage Therapeutics is a private company, so its shares have no public market price. Caplight tracks Viage Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Viage Therapeutics worth (valuation)?
Valuation information for Viage Therapeutics is not publicly available.
Can I buy Viage Therapeutics stock?
Viage Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Viage Therapeutics's last funding round?
Viage Therapeutics's most recent funding round was Seed on January 6, 2022.
Who are the main investors in Viage Therapeutics?
Key investors in Viage Therapeutics include Remiges Ventures.
Will Viage Therapeutics IPO soon?
No public IPO plans have been announced for Viage Therapeutics.
How can I track Viage Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Viage Therapeutics's shares on secondary markets.